COG1410 ApoE Mimetic Peptide | In Vitro Research Compound
Product Name: COG1410
Synonym: ApoE Mimetic Peptide
CAS Number: 878009-24-6
Molecular Formula: C₆₄H₁₂₁N₂₁O₁₄
Molecular Weight: 1408.78 g/mol
Sequence: Ac-AS-{Aib}-LRKL-{Aib}-KRLL-NH₂
Purity: ≥98%
Appearance: Solid, white to off-white
Description
COG1410 is a synthetic peptide derived from the receptor-binding region of apolipoprotein E (ApoE), modified with alpha-aminoisobutyric acid (Aib) residues for structural stability. This compound is utilized in biochemical assays and laboratory models to study cellular receptor binding dynamics, peptide stability, and neuroinflammatory pathway mechanisms in controlled settings.
Research Application & Focus Areas
Laboratory investigations involving COG1410 typically center on:
-
Receptor Interaction Studies: Examining binding affinities with low-density lipoprotein receptor-related proteins (LRP).
-
Cellular Pathways: Investigating intracellular signaling pathways in isolated cellular models.
-
Biochemical Stability: Assessing the enzymatic degradation resistance provided by Aib-modified backbones compared to native peptide sequences.
Storage & Handling
○ −80°C: 3 years
○ −20°C: 2 year
- In Solution (sealed, nitrogen-protected):
○ −80°C: 1 year
○ −20°C: 6 months
- Shipping: Room temperature (within continental US)
Specifications
| Property |
Value |
| Form |
Solid |
| Color |
White to off-white |
| Purity |
>98% |
| Solubility |
Soluble in water or buffer solutions |
| Application |
Research use only (not for injection or human use) |
Where to Buy COG1410 Peptide
Where to buy COG1410 peptide online? Qualitide provide high-purity, research-grade COG1410 ApoE mimetic peptide, available in bulk or small quantities for laboratories, universities, and R&D professionals. Ideal for formulations in brain injury, stroke, and neuroinflammation research.
Disclaimer:
All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, consumption, clinical evaluation, therapeutic, or diagnostic application. By purchasing, you confirm you are a qualified professional and legally permitted to handle these materials in compliance with all applicable laws and regulations.
Related
1. Chiu, L.S., Anderton, R.S., Cross, J.L., Clark, V.W., Edwards, A.B., Knuckey, N.W. & Meloni, B.P., Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury. Transl Neurosci, 2017. 8: p. 147-157.
2. Hoane, M.R., Pierce, J.L., Holland, M.A., Birky, N.D., Dang, T., Vitek, M.P. & McKenna, S.E., The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury. J Neurotrauma, 2007. 24(7): p. 1108-18.
3. Laskowitz, D.T., McKenna, S.E., Song, P., Wang, H., Durham, L., Yeung, N., Christensen, D. & Vitek, M.P., COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. J Neurotrauma, 2007. 24(7): p. 1093-107.
4. Cao, F., Jiang, Y., Wu, Y., Zhong, J., Liu, J., Qin, X., Chen, L., Vitek, M.P., Li, F., Xu, L. & Sun, X., Apolipoprotein E-Mimetic COG1410 Reduces Acute Vasogenic Edema following Traumatic Brain Injury. J Neurotrauma, 2016. 33(2): p. 175-82.
5. Yan, J., Zhang, Y., Wang, L., Li, Z., Tang, S., Wang, Y., Gu, N., Sun, X. & Li, L., TREM2 activation alleviates neural damage via Akt/CREB/BDNF signalling after traumatic brain injury in mice. J Neuroinflammation, 2022. 19(1): p. 289.
6. Tukhovskaya, E.A., Yukin, A.Y., Khokhlova, O.N., Murashev, A.N. & Vitek, M.P., COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia. Journal of neuroscience research, 2009. 87(3): p. 677-82.
7. Wang, H., Anderson, L.G., Lascola, C.D., James, M.L., Venkatraman, T.N., Bennett, E.R., Acheson, S.K., Vitek, M.P. & Laskowitz, D.T., ApolipoproteinE mimetic peptides improve outcome after focal ischemia. Exp Neurol, 2013. 241: p. 67-74.
8. Zhao, R., He, T., Xing, Y. & Luo, J., COG1410 regulates microglial states and protects retinal ganglion cells in retinal ischemia-reperfusion injury. Exp Eye Res, 2023: p. 109678.
9. Pang, J., Peng, J., Matei, N., Yang, P., Kuai, L., Wu, Y., Chen, L., Vitek, M.P., Li, F., Sun, X., Zhang, J.H. & Jiang, Y., Apolipoprotein E Exerts a Whole-Brain Protective Property by Promoting M1? Microglia Quiescence After Experimental Subarachnoid Hemorrhage in Mice. Transl Stroke Res, 2018. 9(6): p. 654-668.
10. Peng, J., Pang, J., Huang, L., Enkhjargal, B., Zhang, T., Mo, J., Wu, P., Xu, W., Zuo, Y., Peng, J., Zuo, G., Chen, L., Tang, J., Zhang, J.H. & Jiang, Y., LRP1 activation attenuates white matter injury by modulating microglial polarization through Shc1/PI3K/Akt pathway after subarachnoid hemorrhage in rats. Redox Biol, 2019. 21: p. 101121.